Unfortunately there was an error in the entry for selexipag in table 2 of this article. Instead of “none” for background therapy it should have stated “‘none, ERA, PDE-5i or both’”. Please find the corrected table below.
Key randomised controlled clinical trials of drugs that target the prostacyclin pathway
Thank you for your interest in spreading the word on European Respiratory Society .
NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.